Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial.
Donners SJA, van Velzen TJ, Cheng SF, Gregson J, Hazewinkel AD, Pizzini FB, Emmer BJ, Simister R, Richards T, Lyrer PA, Maurer M, Smith G, Tervit G, van der Steen L, Pickett GE, Gubitz G, Roozenbeek B, Scheele M, Bamford JM, Kooi ME, de Borst GJ, Jäger HR, Brown MM, Nederkoorn PJ, Bonati LH; ECST-2 investigators.
Donners SJA, et al. Among authors: lyrer pa.
Lancet Neurol. 2025 May;24(5):389-399. doi: 10.1016/S1474-4422(25)00107-3.
Lancet Neurol. 2025.
PMID: 40252662
Free article.
Clinical Trial.